In the present study, we focused on a tumor suppression gene ATBF1, and the expression of ATBF1 was demonstrated to be downregulated by TGF-β treatment along with EMT induction in a dose- and time-dependent manner. This evidence concerns the gene ZFHX3 and neoplasm.